CHICAGO--(BUSINESS WIRE)--TVT2019 – Structural Heart Summit --Materialise (NASDAQ:MTLS), a global 3D printing software and solutions company, has received FDA clearance for its Mimics Enlight ...
Materialise, a 3D printing company with a focus on patient-specific parts, has received FDA clearance for its Mimics Enlight cardiovascular planning software suite. The product’s initial application ...
Introductory Workflow, Mimics Enlight Mitral provides support for transcatheter mitral valve replacements TVT2019 Structural Heart Summit --Materialise (NASDAQ:MTLS), a global 3D printing software and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results